Hormone response

Hormone response refers to the broad physiological and cellular reactions triggered by the interaction of hormones with their specific receptors (NIH, StatPearls) [3, 9, 10]. It is not a single molecular target, but rather a collective term for the activation of diverse signaling pathways, most notably those mediated by the nuclear receptor superfamily—such as the estrogen, androgen, and thyroid hormone receptors—which function as ligand-activated transcription factors [12]. Upon ligand binding, these receptors typically interact with DNA at specific sequences called hormone response elements (HREs) to modulate the expression of genes governing growth, development, and metabolism (PubMed) [4, 8, 12]. In a clinical context, 'hormone response' is often used to characterize the sensitivity of endocrine-related cancers, such as breast or prostate cancer, to therapies that inhibit these signaling cascades [1, 5]. Because the term describes a systemic phenomenon and a large class of biological pathways rather than a discrete actionable protein, it is considered an incorrect designation for a drug target [2, 10]. Successful therapeutic intervention requires targeting specific, well-defined components of the hormone response machinery, such as individual receptors or metabolic enzymes [12, 14].

Other names

Hormonal responseEndocrine responseHormone signaling responseHormone sensitivity

Hormone response is not a single molecular target but a broad physiological process; pharmacological agents typically target this process by acting as agonists or antagonists of specific hormone receptors or by inhibiting the synthesis of the hormones that trigger the response.